Overview

Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout

Status:
Completed
Trial end date:
2001-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of febuxostat, once daily (QD), in reducing serum urate levels in subjects with gout.
Phase:
Phase 2
Details
Lead Sponsor:
Takeda
Treatments:
Febuxostat